Orgenesis Inc. Common Stock
ORGS
ORGS was delisted on the 18th of October, 2024.
0 hedge funds and large institutions have $0 invested in Orgenesis Inc. Common Stock in 2024 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 11 closing their positions.
100% less funds holding
Funds holding: 11 → 0 (-11)
100% less capital invested
Capital invested by funds: $675K → $0 (-$675K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 11
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$406K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
-$170K |
| 3 |
Osaic Holdings
Scottsdale,
Arizona
|
-$44.6K |
| 4 |
BlackRock
New York
|
-$26.6K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$21.2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Vanguard Group
Malvern,
Pennsylvania
| – | -$406K | -91,023 | Closed |
|
|
2
Geode Capital Management
Boston,
Massachusetts
| – | -$170K | -38,037 | Closed |
|
|
3
Osaic Holdings
Scottsdale,
Arizona
| – | -$44.6K | -10,000 | Closed |
|
|
4
BlackRock
New York
| – | -$26.6K | -5,961 | Closed |
|
|
5
UBS Group
Zurich,
Switzerland
| – | -$21.2K | -4,743 | Closed |
|
|
TRCT
6
Tower Research Capital (TRC)
New York
| – | -$6.56K | -1,471 | Closed |
|
7
Citigroup
New York
| – | -$562 | -126 | Closed |
|
8
Bank of America
Charlotte,
North Carolina
| – | -$236 | -53 | Closed |
|
9
JP Morgan Chase
New York
| – | -$40 | -9 | Closed |
|
10
BNP Paribas Financial Markets
Paris,
France
| – | -$31 | -7 | Closed |
|
ORGS Hedge Fund Activity: Q4 2024 in Review
0 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in Orgenesis Inc. Common Stock (ORGS) for Q4 2024, worth a combined $0 — down 100% from $675K a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of ORGS and 0 opened new positions — a net loss of 11 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Vanguard Group, exiting entirely with an estimated $406K sold.
- 0 institutional investors held Orgenesis Inc. Common Stock (ORGS) as of Q4 2024, down from 11 in Q3 2024.
- Funds reported $0 of Orgenesis Inc. Common Stock stock for Q4 2024, down 100% quarter-over-quarter.
- 0 funds opened new Orgenesis Inc. Common Stock positions in Q4 2024 and 11 closed out, a net change of -11 holders.
- The largest Orgenesis Inc. Common Stock seller in Q4 2024 was Vanguard Group, an estimated $406K sold.
Based on aggregated 13F filings for Q4 2024.